- Home
- THRD vs GROY Comparison
THRD vs GROY Comparison
Compare THRD & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- GROY
- Stock Information
- Founded
- THRD 2019
- GROY 2020
- Country
- THRD United States
- GROY Canada
- Employees
- THRD N/A
- GROY N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- GROY
- Sector
- THRD Health Care
- GROY
- Exchange
- THRD Nasdaq
- GROY Nasdaq
- Market Cap
- THRD 232.4M
- GROY 269.3M
- IPO Year
- THRD 2022
- GROY 2021
- Fundamental
- Price
- THRD $5.25
- GROY $1.88
- Analyst Decision
- THRD Hold
- GROY Strong Buy
- Analyst Count
- THRD 3
- GROY 4
- Target Price
- THRD $5.00
- GROY $3.31
- AVG Volume (30 Days)
- THRD 296.2K
- GROY 1.7M
- Earning Date
- THRD 05-08-2025
- GROY 05-07-2025
- Dividend Yield
- THRD N/A
- GROY N/A
- EPS Growth
- THRD N/A
- GROY N/A
- EPS
- THRD N/A
- GROY N/A
- Revenue
- THRD N/A
- GROY $10,347,000.00
- Revenue This Year
- THRD N/A
- GROY $88.55
- Revenue Next Year
- THRD N/A
- GROY $52.87
- P/E Ratio
- THRD N/A
- GROY N/A
- Revenue Growth
- THRD N/A
- GROY 99.94
- 52 Week Low
- THRD $3.18
- GROY $1.16
- 52 Week High
- THRD $16.02
- GROY $1.96
- Technical
- Relative Strength Index (RSI)
- THRD 75.64
- GROY 67.72
- Support Level
- THRD $5.16
- GROY $1.81
- Resistance Level
- THRD $5.22
- GROY $1.96
- Average True Range (ATR)
- THRD 0.04
- GROY 0.08
- MACD
- THRD -0.03
- GROY 0.02
- Stochastic Oscillator
- THRD 100.00
- GROY 84.31
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.